medigraphic.com

2005, Number 3

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2005; 43 (3)

Bloodless Medicine

Rodríguez MH

Language: Spanish
References: 34
Page: 229-235
PDF size: 76.24 Kb.


ABSTRACT

The origin of bloodless medicine was probably generated due to the religious impediment of Jehovah’s witnesses. In 1988 in Brooklyn New York, U.S., a hospital information center was created help Jehovah’s witnesses 24 h/7 days a week. There are 109 branches of these centers in 230 countries throughout the world. Some Jehovah’s witnesses may accept blood derivatives such as immunoglobulin, interferons, topical hemostatic cements, or auto-transfusion tech-niques. At present, there are a substantial number of bloodless surgery procedures including cardiac and orthopedic procedures, and there are 75 hospitals functioning in the U.S. and 105 in additional countries including Italy, Canada, Switzerland, Chile, France, and Australia. For massive blood loss in Jehovah’s witnesses, coordinated work among medical team members is mandatory. The effectiveness of the blood transfusion in the polytraumatized patient is well known. In catastrophic hemorrhage, hyperbaric oxygenations can be of help if sustained as long as necessary to give time for the action of compensatory mechanisms. Nonetheless, transfusion of blood components is needed in surgical cases such as those involving liver, heart, and bone marrow transplantation, as well as in regenerative anemia or thrombocytopenia. Bloodless medicine costs are lower, but there is no precise way to estimate the costs of resources and other concepts for the operation of bloodless medicine. Alternatives such as auto-donation prior to surgery or acute normovolemic hemo-dilution can be proposed to patients who reject allogenic blood transfusion.


REFERENCES

  1. Surgical and other invasive procedures performed without blood transfusion or blood products. Veteran Health administration. Washington DC 20420 S/T Sanders for TL Garthwaite MD. E-mailed 8/15/2001.

  2. Case Reports in Bloodless Medicine and Surgery. www.med.unipi.it/patchir/blood/bmr/cases.htm

  3. Wilcox PD. Blood-from perspective of Jehova’s witnesees in bloodless medicine and surgery. En: Culotta E, ed. The new standard of care workshop. Washington DC: AABB; 2000.

  4. Graziani J. Status and development of bloodless medicine and surgery. En: Culotta E, ed. The new standard of care workshop. Washington DC: AABB; 2000.

  5. Bartlet R. Current concepts and clinical strategies in bloodless medicine and surgery. En: Culotta E, ed. The new standard of care workshop. Washington

  6. DC: AABB; 2000.

  7. Shander A. Application and implementation bloodless medicine and surgery. En: Culotta E, ed. The new standard of care workshop. Washington DC: AABB; 2000.

  8. Mollison PL, Engelfried CP, Contreras M. Blood transfusion in clinical medicine. Tenth edition. NY: Blackwell Science Ltd: 1997. p. 290.

  9. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar B. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 2004;44:632-644.

  10. Hebert PC, Wells G, Blajchman MA, Marshal J, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl

  11. J Med 1999;340:409-417.

  12. Ridley J, Revell P, Ainsworth M, Pryce A. Transfusion for anaemia in the district hospital setting. Transfusion Medicine 2003;13:73-75

  13. Audet AM, Goodnough LT. Practice strategies for elective red blood cells transfusion. Ann Intern Med 1992;116:403-406.

  14. Kovesi T, Royston D. Pharmacological approaches to reducing allogeneic blood exposure. Vox Sanguinis 2003;84:2.

  15. Brecher ME, Goodnough LT. The rise and fall of preoperative autologous blood donation. Transfusion 2001;41:1459-1462.

  16. Rock G, Bormanis J, Beard J, Saadany EI, Giplivi A. A retrospective analysis of an autologous blood program. CSTM/CBS Abstracts. Abstract 8. Transfusion Medicine 2001;11:395.

  17. Kickler TS. Why bloodless medicine and how should we do it? Transfusion 2003;43:550-552.

  18. Goodnough LT, Shander A, Spence R. Bloodless medicine: critical care without allogenic blood transfusion. Transfusion 2003;43:668-676.

  19. Surgical and other invasive procedures performed without blood transfusion or blood products. Veteran Health administration. Washington DC 20420 S/T Sanders for TL Garthwaite MD. E-mailed 8/15/2001.

  20. Case Reports in Bloodless Medicine and Surgery. www.med.unipi.it/patchir/blood/bmr/cases.htm

  21. Wilcox PD. Blood-from perspective of Jehova’s witnesees in bloodless medicine and surgery. En: Culotta E, ed. The new standard of care workshop. Washington DC: AABB; 2000.

  22. Graziani J. Status and development of bloodless medicine and surgery. En: Culotta E, ed. The new standard of care workshop. Washington DC: AABB; 2000.

  23. Bartlet R. Current concepts and clinical strategies in bloodless medicine and surgery. En: Culotta E, ed. The new standard of care workshop. Washington DC: AABB; 2000.

  24. Shander A. Application and implementation bloodless medicine and surgery. En: Culotta E, ed. The new standard of care workshop. Washington DC: AABB; 2000.

  25. Mollison PL, Engelfried CP, Contreras M. Blood transfusion in clinical medicine. Tenth edition. NY: Blackwell Science Ltd: 1997. p. 290.

  26. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar B. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion 2004;44:632-644.

  27. Hebert PC, Wells G, Blajchman MA, Marshal J, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-417.

  28. Ridley J, Revell P, Ainsworth M, Pryce A. Transfusion for anaemia in the district hospital setting. Transfusion Medicine 2003;13:73-75

  29. Audet AM, Goodnough LT. Practice strategies for elective red blood cells transfusion. Ann Intern Med 1992;116:403-406.

  30. Kovesi T, Royston D. Pharmacological approaches to reducing allogeneic blood exposure. Vox Sanguinis 2003;84:2.

  31. Brecher ME, Goodnough LT. The rise and fall of preoperative autologous blood donation. Transfusion 2001;41:1459-1462.

  32. Rock G, Bormanis J, Beard J, Saadany EI, Giplivi A. A retrospective analysis of an autologous blood program. CSTM/CBS Abstracts. Abstract 8. Transfusion Medicine 2001;11:395.

  33. Kickler TS. Why bloodless medicine and how should we do it? Transfusion 2003;43:550-552.

  34. Goodnough LT, Shander A, Spence R. Bloodless medicine: critical care without allogenic blood transfusion. Transfusion 2003;43:668-676.




2020     |     www.medigraphic.com